Novo Nordisk hemophilia drug Frehemgo recommended for EU approval
A European Medicines Agency panel recommended approval of Frehemgo, Novo Nordisk’s injectable hemophilia treatment.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.